HematologyBeginner

Padua Prediction Score for Medical Inpatient VTE Prophylaxis (CHEST Guidelines)

Calculates Padua VTE Score (0–20) to identify hospitalized medical patients needing pharmacologic thromboprophylaxis (Score ≥ 4).

Clinical Parameters

12 Variables

Awaiting Clinical Parameters

Configure the patient variables on the left and select Calculate Result to generate the clinical score and stratification.

Verified 2026 GuidelinesInstant Calculation
Jump to Formula & Clinical Protocol ↓
Advertisement
High Yield Prometric TopicHematology

Tested on Gulf Medical Boards (DHA, SMLE, MOH & HAAD)

Clinical calculations and diagnostic scoring systems like Padua Prediction Score for Medical Inpatient VTE Prophylaxis (CHEST Guidelines) frequently appear on Prometric exams. Master high-yield clinical vignettes with instant AI-powered pathophysiology rationales.

Clinical Significance & Diagnostic Standard
2026 Clinical Reference

What is the Padua Prediction Score for Medical Inpatient VTE Prophylaxis (CHEST Guidelines)?

📋Clinical Summary & Definition Capsule

The Padua Prediction Score for Medical Inpatient VTE Prophylaxis (CHEST Guidelines) is an evidence-based clinical decision rule engineered to quantify diagnostic probability, stratify clinical severity, and guide therapeutic decision-making in hematology practice. Implements the CHEST-recommended Padua Prediction Score to stratify venous thromboembolism (VTE) risk in non-surgical medical inpatients, recommending pharmacologic anticoagulation for high-risk scores (≥ 4 points). Clinical scoring tools like Padua Prediction Score for Medical Inpatient VTE Prophylaxis (CHEST Guidelines) are essential in acute and outpatient management, enabling clinicians to objectively differentiate between low-risk candidates suitable for conservative therapy and high-risk patients requiring urgent interventions. Verified against current 2026 clinical standards, this tool is extensively tested on Gulf health authority licensing exams including DHA (Dubai), SMLE (Saudi Arabia), MOH, HAAD/DOH (Abu Dhabi), OMSB (Oman), and QCHP (Qatar).

💡Clinical Pearls & Diagnostic Utility

Reduces hospital-acquired pulmonary embolisms and deep vein thromboses while preventing inappropriate anticoagulation bleeding in low-risk medical patients.

Mathematical Formulation

Formula & Calculation Parameters

The mathematical equation and clinical variables required to calculate Padua Prediction Score for Medical Inpatient VTE Prophylaxis (CHEST Guidelines):

Padua Score = Sum of 11 clinical risk factors (Range 0 to 20)
Score ≥ 4 indicates high VTE risk warranting pharmacologic prophylaxis.
Risk Stratification

Score Interpretation & Clinical Stratification

Score RangeClinical InterpretationRisk Tier
≤ 3Low Risk of VTE (< 4 points / Pharmacologic Prophylaxis NOT routinely needed)green
≥ 4High Risk of VTE (≥ 4 points / Pharmacologic Thromboprophylaxis Strongly Recommended)red
Clinical Limitations & Contraindications

When to Exercise Caution

Designed specifically for non-surgical medical inpatients; surgical patients should be evaluated with the Caprini VTE risk model.

Sponsored Content
Medical Review & Guidelines Compliance
MD

Clinical Review Board

Dr. Muhammad Nouman, MBBS

Capital Medical University | PMDC Reg No: 117744-P

Clinical Audit Status

✓ Verified for 2026 Guidelines

Last updated: 2026-08-08

Peer-Reviewed Medical Literature

  • Barbar S, et al. A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score. J Thromb Haemost. 2010;8(11):2450-2457.
  • Kahn SR, et al. Prevention of VTE in nonsurgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 Suppl):e195S-e226S.
Advertisement